{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:17:24Z","timestamp":1775002644978,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["1401\\u20134-233\\u201364986"],"award-info":[{"award-number":["1401\\u20134-233\\u201364986"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.msard.2025.106640","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:13:07Z","timestamp":1753369987000},"page":"106640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessment of different types of headaches, their prevalence, and contributing factors on neuromyelitis optica spectrum disorder patients"],"prefix":"10.1016","volume":"103","author":[{"given":"Parisa","family":"Sharifi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoureh","family":"Togha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Ebadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazaleh","family":"Pourhosseini Akbarieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-0911","authenticated-orcid":false,"given":"Abdorreza","family":"Naser Moghadasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.msard.2025.106640_bib0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10072-020-04809-4","article-title":"Headache in the development of neurosciences","volume":"41","author":"Agostoni","year":"2020","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2025.106640_bib0067","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10072-020-04643-8","article-title":"Gender-related differences in migraine","volume":"41","author":"Allais","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106640_bib0052","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-13-33","article-title":"Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study","volume":"13","author":"Asgari","year":"2013","journal-title":"BMC Neurol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2025.106640_bib0051","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2012.09.010","article-title":"Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid","volume":"254","author":"Asgari","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106640_bib0024","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fneur.2020.00778","article-title":"Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies","volume":"11","author":"Asseyer","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106640_bib0028","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1212\/NXI.0000000000000985","article-title":"Pain, depression, and quality of life in neuromyelitis optica spectrum disorder","volume":"8","author":"Ayzenberg","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106640_bib0034","first-page":"175","article-title":"Migraine and neurological disorders comorbidity-consideration of sinus hypoxic nitric oxide theory for migraine","volume":"2","author":"Bandara","year":"2014","journal-title":"J. Neurol. Disord."},{"key":"10.1016\/j.msard.2025.106640_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102685","article-title":"Frequency of comorbidities in neuromyelitis optica spectrum disorder","volume":"48","author":"Barzegar","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106640_bib0010","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fneur.2018.00888","article-title":"Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis","volume":"9","author":"Borisow","year":"2018","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106640_bib0007","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/1352458516671203","article-title":"Influence of female sex and fertile age on neuromyelitis optica spectrum disorders","volume":"23","author":"Borisow","year":"2017","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2025.106640_bib0041","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","article-title":"Pain in neuromyelitis optica\u2013prevalence, pathogenesis and therapy","volume":"10","author":"Bradl","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106640_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s10194-021-01281-z","article-title":"Comorbidities of primary headache disorders: a literature review with meta-analysis","volume":"22","author":"Caponnetto","year":"2021","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.msard.2025.106640_bib0002","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106640_bib0048","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.msard.2017.11.004","article-title":"Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: a cohort of Latin American patients","volume":"19","author":"Carnero Contentti","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2025.106640_bib0062","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5223\/pghn.2013.16.3.171","article-title":"Adverse events associated with azathioprine treatment in korean pediatric inflammatory bowel disease patients","volume":"16","author":"Chun","year":"2013","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"issue":"5","key":"10.1016\/j.msard.2025.106640_bib0040","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1212\/NXI.0000000000000583","article-title":"Collaborative international research in clinical and longitudinal experience study in NMOSD","volume":"6","author":"Cook","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10206","key":"10.1016\/j.msard.2025.106640_bib0059","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(19)31817-3","article-title":"Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2\/3 trial","volume":"394","author":"Cree","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.msard.2025.106640_bib0022","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1526-4610.2009.01427.x","article-title":"Frequency of chronic headaches in Japanese patients with multiple sclerosis: with special reference to opticospinal and common forms of multiple sclerosis","volume":"49","author":"Doi","year":"2009","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.msard.2025.106640_bib0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/nmt-2020-0046","article-title":"Satralizumab in the treatment of neuromyelitis optica spectrum disorder","volume":"11","author":"Duchow","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"issue":"3","key":"10.1016\/j.msard.2025.106640_bib0044","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7224\/1537-2073.2021-019","article-title":"Sleep quality in neuromyelitis optica spectrum disorder: a systematic review","volume":"24","author":"Eshtiaghi","year":"2022","journal-title":"Int. J. MS Care"},{"issue":"3","key":"10.1016\/j.msard.2025.106640_bib0021","first-page":"165","article-title":"Relative frequency of primary headaches in patients with neuromyelitis optica spectrum disorder: a cross-sectional study","volume":"23","author":"Etemadifar","year":"2024","journal-title":"Curr. J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106640_bib0008","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106640_bib0061","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40263-023-00995-9","article-title":"A review in neuromyelitis optica spectrum disorder","volume":"37","author":"Fung","year":"2023","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.msard.2025.106640_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084154","article-title":"Adverse events in NMOSD therapy","volume":"23","author":"Giglhuber","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106640_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106606","article-title":"Sleep disorders as a possible predisposing attack factor in neuromyelitis optica spectrum disorder (NMOSD): a case-control study","volume":"204","author":"Haji Molla Rabi","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3","key":"10.1016\/j.msard.2025.106640_bib0042","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00401-018-1950-8","article-title":"Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat","volume":"137","author":"Hillebrand","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2025.106640_bib0009","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106640_bib0030","first-page":"46","article-title":"Neuromyelitis optica spectrum disorder in China: quality of life and medical care experience","author":"Huang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2025.106640_bib0063","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2025.106640_bib0003","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106640_bib0049","article-title":"Brain abnormalities in neuromyelitis optica spectrum disorder","volume":"2012","author":"Kim","year":"2012","journal-title":"Mult. Scler. Int."},{"issue":"8","key":"10.1016\/j.msard.2025.106640_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273220","article-title":"Primary headaches increase the risk of dementias: an 8-year nationwide cohort study","volume":"17","author":"Kim","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.msard.2025.106640_bib0011","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2025.106640_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-2982.2009.01904.x","article-title":"Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study","volume":"30","author":"Kruit","year":"2010","journal-title":"Cephalalgia"},{"issue":"Suppl 3","key":"10.1016\/j.msard.2025.106640_bib0033","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1007\/s10072-004-0275-7","article-title":"Headache and inflammatory disorders of the central nervous system","volume":"25","author":"La Mantia","year":"2004","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106640_bib0064","first-page":"339","article-title":"A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms","volume":"20","author":"Langarizadeh","year":"2021","journal-title":"Excli J."},{"issue":"9451","key":"10.1016\/j.msard.2025.106640_bib0005","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.msard.2025.106640_bib0053","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1474-4422(09)70133-4","article-title":"Pathophysiology of trigeminal autonomic cephalalgias","volume":"8","author":"Leone","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106640_bib0027","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12883-022-02841-9","article-title":"The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study","volume":"22","author":"Li","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2025.106640_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105007","article-title":"The prevalence of depression, anxiety, and sleep disturbances in patients with neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis","volume":"79","author":"Liu","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2025.106640_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020090","article-title":"Aquaporin-4 water channel in the brain and its implication for health and disease","volume":"8","author":"Mader","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.msard.2025.106640_bib0013","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11916-017-0620-1","article-title":"Headache in neuromyelitis optica","volume":"21","author":"Masters-Israilov","year":"2017","journal-title":"Curr. Pain Headache Rep."},{"issue":"3","key":"10.1016\/j.msard.2025.106640_bib0029","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7224\/1537-2073.2017-076","article-title":"Assessment of patients with neuromyelitis optica spectrum disorder using the EQ-5D","volume":"21","author":"Mealy","year":"2019","journal-title":"Int. J. MS Care"},{"issue":"4","key":"10.1016\/j.msard.2025.106640_bib0039","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1212\/NXI.0000000000000134","article-title":"Update on biomarkers in neuromyelitis optica","volume":"2","author":"Melamed","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.msard.2025.106640_bib0046","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.nrl.2022.06.004","article-title":"The prevalence, incidence, and clinical assessment of neuromyelitis optica spectrum disorder in patients with demyelinating diseases","volume":"39","author":"Mireles-Ram\u00edrez","year":"2024","journal-title":"Neurolog\u00eda"},{"issue":"1","key":"10.1016\/j.msard.2025.106640_bib0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/1756-185X.13427","article-title":"Rituximab-associated posterior reversible encephalopathy syndrome","volume":"22","author":"Mustafa","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.msard.2025.106640_bib0058","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s40263-022-00949-7","article-title":"Inebilizumab: a review in neuromyelitis optica spectrum disorder","volume":"36","author":"Nie","year":"2022","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.msard.2025.106640_bib0006","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult. Scler."},{"issue":"13","key":"10.1016\/j.msard.2025.106640_bib0026","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/03331024211018138","article-title":"A brief diagnostic screen for cluster headache: creation and initial validation of the Erwin test for cluster headache","volume":"41","author":"Parakramaweera","year":"2021","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.msard.2025.106640_bib0057","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4\u2013positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock Sean","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.msard.2025.106640_bib0015","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/archneurol.2012.768","article-title":"Association of neuromyelitis optica with severe and intractable pain","volume":"69","author":"Qian","year":"2012","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106640_bib0019","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjmed.2017.09.005","article-title":"Headache","volume":"131","author":"Rizzoli","year":"2018","journal-title":"Am. J. Med."},{"key":"10.1016\/j.msard.2025.106640_bib0068","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/jwh.2018.7274","article-title":"Sex and gender differences in migraine\u2014Evaluating knowledge gaps","volume":"27","author":"Schroeder","year":"2018","journal-title":"J. Women's Health"},{"key":"10.1016\/j.msard.2025.106640_bib0047","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211014389","article-title":"A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course","volume":"14","author":"Solomon","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"5","key":"10.1016\/j.msard.2025.106640_bib0018","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1526-4610.1990.hed3005273.x","article-title":"Demographics of headache in elderly patients","volume":"30","author":"Solomon","year":"1990","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.msard.2025.106640_bib0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","article-title":"The global burden of headache: a documentation of headache prevalence and disability worldwide","volume":"27","author":"Stovner","year":"2007","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.msard.2025.106640_bib0066","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/1028415X.2023.2218563","article-title":"Age and sex differences in the association between dietary inflammatory index and severe headache or migraine: a nationwide cross-sectional study","volume":"27","author":"Sun","year":"2024","journal-title":"Nutr. Neurosci."},{"issue":"9","key":"10.1016\/j.msard.2025.106640_bib0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","year":"2013","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.msard.2025.106640_bib0038","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bpa.12097","article-title":"Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications","volume":"24","author":"Uzawa","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2025.106640_bib0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.msksp.2017.07.001","article-title":"Development and psychometric validation of the headache screening questionnaire - Dutch version","volume":"31","author":"van der Meer","year":"2017","journal-title":"Musculoskelet. Sci. Pr."},{"issue":"13","key":"10.1016\/j.msard.2025.106640_bib0037","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1177\/0333102418784698","article-title":"Brain structure and function related to headache: brainstem structure and function in headache","volume":"39","author":"Vila-Pueyo","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.msard.2025.106640_bib0056","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211056710","article-title":"Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1086","key":"10.1016\/j.msard.2025.106640_bib0012","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170690","article-title":"Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review","volume":"91","author":"Wang","year":"2018","journal-title":"Br. J. Radiol."},{"issue":"5","key":"10.1016\/j.msard.2025.106640_bib0023","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00415-014-7298-7","article-title":"Comparative clinical characteristics of neuromyelitis optica spectrum disorders with and without medulla oblongata lesions","volume":"261","author":"Wang","year":"2014","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106640_bib0016","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2025.106640_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2025.106640_bib0014","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106640_bib0065","series-title":"Corticosteroid Adverse Effects","author":"Yasir","year":"2025"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:21:30Z","timestamp":1774999290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":68,"alternative-id":["S2211034825003827"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106640","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of different types of headaches, their prevalence, and contributing factors on neuromyelitis optica spectrum disorder patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106640"}}